Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
F 3.83 -10.94% -0.47
SAVA closed down 10.94 percent on Tuesday, November 26, 2024, on 7.5 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 7 hours ago
Fell Below Previous Day's Low about 9 hours ago
New 52 Week Low about 9 hours ago
Down 10% about 10 hours ago
60 Minute Opening Range Breakdown about 10 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Abnormal Psychology Transdermal

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.2
52 Week Low 3.65
Average Volume 4,387,317
200-Day Moving Average 22.75
50-Day Moving Average 26.53
20-Day Moving Average 24.35
10-Day Moving Average 22.70
Average True Range 3.91
RSI (14) 23.08
ADX 19.5
+DI 16.95
-DI 45.65
Chandelier Exit (Long, 3 ATRs) 22.26
Chandelier Exit (Short, 3 ATRs) 15.37
Upper Bollinger Bands 38.24
Lower Bollinger Band 10.47
Percent B (%b) -0.24
BandWidth 114.01
MACD Line -3.10
MACD Signal Line -0.92
MACD Histogram -2.1784
Fundamentals Value
Market Cap 161.56 Million
Num Shares 42.2 Million
EPS -2.29
Price-to-Earnings (P/E) Ratio -1.67
Price-to-Sales 0.00
Price-to-Book 6.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.85
Resistance 3 (R3) 4.90 4.62 4.68
Resistance 2 (R2) 4.62 4.36 4.59 4.62
Resistance 1 (R1) 4.22 4.19 4.08 4.17 4.56
Pivot Point 3.94 3.94 3.86 3.91 3.94
Support 1 (S1) 3.54 3.68 3.40 3.49 3.09
Support 2 (S2) 3.26 3.51 3.23 3.03
Support 3 (S3) 2.86 3.26 2.98
Support 4 (S4) 2.81